glucose, (beta-d)-isomer has been researched along with Peripheral Arterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, GC; Heyward, J; Mansour, O; Olson, L; Singh, S | 1 |
| Guyatt, G; Hao, Q | 1 |
| Al-Omran, M; Fitchett, D; George, JT; Hehnke, U; Inzucchi, SE; Mazer, CD; Verma, S; Zinman, B | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Peripheral Arterial Disease
| Article | Year |
|---|---|
Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis.
Topics: Amputation, Surgical; Benzhydryl Compounds; Glucosides; Humans; Lower Extremity; Peripheral Arterial Disease; Randomized Controlled Trials as Topic; Risk; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds | 2020 |
1 trial(s) available for glucose, (beta-d)-isomer and Peripheral Arterial Disease
| Article | Year |
|---|---|
Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Male; Middle Aged; Peripheral Arterial Disease; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2018 |
1 other study(ies) available for glucose, (beta-d)-isomer and Peripheral Arterial Disease
| Article | Year |
|---|---|
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Kidney; Peripheral Arterial Disease; Sodium-Glucose Transporter 2 Inhibitors | 2021 |